+1-518-621-2074 | US-Canada Toll Free Contact Us

Implantable Medical Devices Market to Remain Significant Part of U.S. Healthcare Framework: Here’s why

about us

Published on : Apr 19, 2016

Medical implants are specifically fabricated to be used as a substitute to ruptured or lost parts in the human body. These implants are also used as supporting devices that aid bones and tissues grow again after an injury or medical procedure. Contrary to this, medical transplant involves surgically replacing an organ with a natural organ received by a donor. Due to the artificial nature of medical implants, sometimes they are not intended to be remain in the body for a life time. 

In U.S., the implantable medical devices market is poised to exhibit a health growth in the future years. The primary drivers that will propel growth of this market are factors augmenting the number of patients that will require implants. Across the world, the rising geriatric population has been a significant reason contributing to the revenue of a myriad healthcare-related industries, which includes the U.S. market for implantable medical devices. With the baby boomer era slowing drawing to a close, the rising percentage of geriatrics around the world will benefit this market.

Meanwhile, the market for cosmetic implant devices exhibits an expeditious growth rate thanks to increasing income levels of the middle class population that can afford cosmetic implants. Dental implants is another major product segment that is experiencing an upswing in this market. This includes permanent denture implantation, tooth replacements, cavity fixings, and smile reconstruction procedures that are most-sought after today.

Recently, a release by the U.S. Food and Drug Administration stated that implant devices could interfere with CT scan. Published on March 31, 2016 the safety alert stated of recording a small list of negative observations that could be associated to interference of CT scanner with implant devices. The implants include insulin pumps, electronic implantable cardiac devices, and neurostimulators. To redress this, FDA suggested that CT scan could be performed if operators were aware of the implant devices and kept primary X-ray stream away from the implant.